This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Canadian Agency for Drugs and Technologies in Health (CADTH). Neuro-linguistic programming for the treatment of adults with post-traumatic stress disorder, general anxiety disorder, or depression: a review of clinical effectiveness and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary with Critical Appraisal. 2014
No clinical evidence on NLP for the treatment of adults with PTSD, GAD, or depression was identified. A SIGN (Scottish Intercollegiate Guidelines Network) guideline reported that no evidence specific to depression and meeting guideline inclusion criteria was identified on the use of NLP.
Subject indexing assigned by CRD
Anxiety Disorders; Depression; Depressive Disorder; Neurolinguistic Programming; Psychotherapys
Country of organisation
An English language summary is available.
Address for correspondence
Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: email@example.com
Date abstract record published